PDUFAconf 0.98
patisiran — PDUFA
$ALNY · ALNYLAM PHARMACEUTICALS, INC. · cardiomyopathy of transthyretin-mediated (ATTR) amyloidosis
Event date
October 8, 2023
972 days ago
Sponsor runway
cash-flow +
$1.66B liquid
Evidence
Comparable historical pdufas· last 5 years · same event type
75% hit rate (3/4)
| Ticker | Drug | Date | Outcome |
|---|---|---|---|
| $RCKT | kresladi | 2026-03-28 | success |
| $RYTM | imcivree | 2026-03-20 | success |
| $CYTK | aficamten | 2025-12-26 | unknown |
| $ALDX | reproxalap | 2025-12-16 | unknown |
| $BCRX | orladeyo | 2025-12-12 | success |
| $OMER | narsoplimab | 2025-09-25 | unknown |
| $BCRX | orladeyo (berotralstat) | 2025-09-12 | unknown |
| $ETON | et-400 | 2025-05-28 | unknown |
| $ALDX | reproxalap | 2025-04-02 | failure |
| $IONS | olezarsen | 2024-12-19 | unknown |
Recent insider activity· ±90 days
5 insiders · 0 buys · 35 sells
Sell10b5-1
2023-12-27BONNEY MICHAEL W
Director
30,000 @ $195.00$5.85M
Exercise10b5-1
2023-12-27BONNEY MICHAEL W
Director
30,000 @ $96.45$2.89M
Sell
2023-08-07Garg Pushkal
EVP Chief R&D
240 @ $185.32$44K
Sell
2023-08-07Garg Pushkal
EVP Chief R&D
3,112 @ $183.58$571K
Sell
2023-08-07Garg Pushkal
EVP Chief R&D
814 @ $184.65$150K
Sell
2023-08-04Garg Pushkal
EVP Chief R&D
15 @ $188.40$3K
Sell
2023-08-04Garg Pushkal
EVP Chief R&D
164 @ $189.31$31K
Sell
2023-08-04Poulton Jeffrey V.
EVP, Chief Financial Officer
944 @ $186.39$176K
Sell
2023-08-04Garg Pushkal
EVP Chief R&D
658 @ $184.70$122K
Sell
2023-08-04Garg Pushkal
EVP Chief R&D
1,593 @ $185.54$296K
Sell
2023-08-04Garg Pushkal
EVP Chief R&D
945 @ $186.39$176K
Sell
2023-08-04Garg Pushkal
EVP Chief R&D
86 @ $187.37$16K
Sell
2023-08-04Poulton Jeffrey V.
EVP, Chief Financial Officer
1,593 @ $185.54$296K
Sell
2023-08-04Poulton Jeffrey V.
EVP, Chief Financial Officer
86 @ $187.37$16K
Sell
2023-08-04Poulton Jeffrey V.
EVP, Chief Financial Officer
15 @ $188.40$3K
Sell
2023-08-04Poulton Jeffrey V.
EVP, Chief Financial Officer
164 @ $189.31$31K
Sell
2023-08-04Greenstreet Yvonne
Chief Executive Officer
771 @ $184.70$142K
Sell
2023-08-04Greenstreet Yvonne
Chief Executive Officer
1,869 @ $185.54$347K
Sell
2023-08-04Greenstreet Yvonne
Chief Executive Officer
1,107 @ $186.39$206K
Sell
2023-08-04Greenstreet Yvonne
Chief Executive Officer
101 @ $187.37$19K
Sell
2023-08-04Greenstreet Yvonne
Chief Executive Officer
17 @ $188.40$3K
Sell
2023-08-04Greenstreet Yvonne
Chief Executive Officer
192 @ $189.31$36K
Sell
2023-08-04Vaishnaw Akshay
President
771 @ $184.70$142K
Sell
2023-08-04Vaishnaw Akshay
President
1,869 @ $185.54$347K
Sell
2023-08-04Vaishnaw Akshay
President
1,107 @ $186.39$206K
Sell
2023-08-04Vaishnaw Akshay
President
101 @ $187.37$19K
Sell
2023-08-04Vaishnaw Akshay
President
17 @ $188.40$3K
Sell
2023-08-04Vaishnaw Akshay
President
192 @ $189.31$36K
Sell
2023-08-04Poulton Jeffrey V.
EVP, Chief Financial Officer
658 @ $184.70$122K
Grant
2023-08-03Garg Pushkal
EVP Chief R&D
3,109 @ ——
Grant
2023-08-03Poulton Jeffrey V.
EVP, Chief Financial Officer
4,518 @ ——
Grant
2023-08-03Poulton Jeffrey V.
EVP, Chief Financial Officer
3,109 @ ——
Sell
2023-08-03BONNEY MICHAEL W
Director
300 @ $181.08$54K
Grant
2023-08-03Vaishnaw Akshay
President
5,082 @ ——
Grant
2023-08-03Garg Pushkal
EVP Chief R&D
4,518 @ ——
Grant
2023-08-03Vaishnaw Akshay
President
3,859 @ ——
Sell
2023-08-03BONNEY MICHAEL W
Director
500 @ $182.45$91K
Sell
2023-08-03BONNEY MICHAEL W
Director
560 @ $183.75$103K
Grant
2023-08-03Greenstreet Yvonne
Chief Executive Officer
5,082 @ ——
Grant
2023-08-03Greenstreet Yvonne
Chief Executive Officer
3,859 @ ——
Sell
2023-08-03BONNEY MICHAEL W
Director
1,535 @ $184.89$284K
Sell
2023-08-03BONNEY MICHAEL W
Director
1,714 @ $185.99$319K
Sell
2023-08-03BONNEY MICHAEL W
Director
1,389 @ $187.04$260K
Sell
2023-08-03BONNEY MICHAEL W
Director
450 @ $187.71$84K
Exercise
2023-08-02BONNEY MICHAEL W
Director
22,477 @ ——